BHC vs CUBE · rev $9.63B vs P/E 25, rev $1.07B
Bausch Health Companies Inc (BHC) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Bausch Health Companies Inc (BHC) is a drug manufacturers - specialty & generic company listed on NYSE.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported BHC revenue for 2024-12-31 was $9.63B. Net income was -$72.0M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. BHC currently screens at market cap $1.78B.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
BHC currently screens at market cap $1.78B. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the BHC and CUBE stock pages for the full models.
Not investment advice.